NCT02952469View on ClinicalTrials.gov

Biodistribution/Reproducibility Ga-68 PSMA-HBED-CC

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 14, 2016

Primary Completion Date

April 25, 2022

Study Completion Date

April 25, 2022

Conditions
Prostatic Neoplasms
Interventions
DRUG

(68Ga)PSMA-HBED-CC

Experimental radiotracer for imaging prostate cancer

Trial Locations (1)

52242

Holden Comprehensive Cancer Center, Iowa City

All Listed Sponsors
lead

University of Iowa

OTHER

NCT02952469 - Biodistribution/Reproducibility Ga-68 PSMA-HBED-CC | Biotech Hunter | Biotech Hunter